SCHEMBL5835247

SCHEMBL5835247

CCN(CC)c1ccc(NC(=O)C2(C)CCc3cccc(OC)c3C2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 7/20 0.64
KCNH2 Q12809 1/20 0.64
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
POLB P06746 1/20 0.45
MAPT P10636 5/20 0.43
ALDH1A1 P00352 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
MAPK1 P28482 1/20 0.41
GFER P55789 1/20 0.41
MCL1 Q07820 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
NOX1 Q9Y5S8 1/20 0.40
MTNR1A P48039 2/20 0.40
MTNR1B P49286 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5835065 0.79 GHSR (0.80) GHSRKCNH2MEN1KMT2APOLB
SCHEMBL5835361 0.79 GHSR (1.00) GHSRKCNH2MEN1KMT2APOLB
SCHEMBL5835134 0.76 ADRA2A (0.48) GHSRKCNH2MAPTALDH1A1MTNR1A
SCHEMBL5835352 0.75 GHSR (0.71) GHSRKCNH2MEN1KMT2APOLB
SCHEMBL5834865 0.74 MAPT (0.56) GHSRKCNH2MEN1KMT2APOLB
SCHEMBL5834877 0.70 GHSR (0.59) GHSRKCNH2MEN1KMT2APOLB
SCHEMBL5835129 0.70 GHSR (0.59) GHSRKCNH2MEN1KMT2APOLB
SCHEMBL5835734 0.68 GHSR (0.74) GHSRKCNH2MEN1KMT2APOLB
SCHEMBL5835090 0.68 GHSR (0.77) GHSRKCNH2MEN1KMT2APOLB
SCHEMBL5835225 0.68 GHSR (0.57) GHSRKCNH2MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US claimed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US claimed
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US disclosed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators GPR119, GHSR, GIPR GHSR 2/4885KCNH2 3931/4885MEN1 1271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.